HIV elite controllers: Difference between revisions
From IDWiki
(Created page with "== Background == === Definition === * Variably defined, but the common thread is that of someone who maintains an undetectable viral load despite not being on treatment * One...") Â |
(→â€: added pathophys)  |
||
Line 8: | Line 8: | ||
* Exact prevalence depends on the definition |
* Exact prevalence depends on the definition |
||
* Many elite controllers will eventually have breakthrough |
* Many elite controllers will eventually have breakthrough |
||
=== Pathophysiology === |
|||
* Unclear; likely multifactorial |
|||
* Host genetics |
|||
** HLA type |
|||
** Heterozygous CCR5 deletion mutation |
|||
** Mannose-binding lectin alleles |
|||
** Tumour necrosis factor c2 microsatellite alleles |
|||
** Gc vitamin D-binding factor alleles |
|||
* Host immunity |
|||
** Effective cytotoxic T-cell responses |
|||
** Secretion of CD8 antiviral factor |
|||
** Secretion of chemokines that block HIV entry co-receptors (CCR5 and CXCR4) |
|||
** Maintenance of functional lymphoid tissue architecture |
|||
* Virus |
|||
** Attenuated strain of [[HIV]] |
|||
== Management == |
== Management == |
Latest revision as of 00:13, 8 February 2020
Background
Definition
- Variably defined, but the common thread is that of someone who maintains an undetectable viral load despite not being on treatment
- One possible definition is someone with 3 or more undetectable viral loads over at least 12 months
Epidemiology
- Represents about 1% of people living with HIV
- Exact prevalence depends on the definition
- Many elite controllers will eventually have breakthrough
Pathophysiology
- Unclear; likely multifactorial
- Host genetics
- HLA type
- Heterozygous CCR5 deletion mutation
- Mannose-binding lectin alleles
- Tumour necrosis factor c2 microsatellite alleles
- Gc vitamin D-binding factor alleles
- Host immunity
- Effective cytotoxic T-cell responses
- Secretion of CD8 antiviral factor
- Secretion of chemokines that block HIV entry co-receptors (CCR5 and CXCR4)
- Maintenance of functional lymphoid tissue architecture
- Virus
- Attenuated strain of HIV
Management
- Unclear how much benefit they get from HIV treatment